Literature DB >> 26433522

Hybrid Procedure for Neonates With Hypoplastic Left Heart Syndrome at High-Risk for Norwood: Midterm Outcomes.

Michael O Murphy1, Hannah Bellsham-Revell2, Gareth J Morgan2, Thomas Krasemann2, Eric Rosenthal2, Shakeel A Qureshi2, Caner Salih2, Conal B Austin2, David R Anderson2.   

Abstract

BACKGROUND: Hybrid procedure offers patients with severe congenital heart disease an alternative initial procedure to conventional surgical reconstruction. We report the midterm outcomes of a cohort of neonates who had a hybrid procedure for variants of hypoplastic left heart syndrome because they were at high risk for the Norwood procedure.
METHODS: Between December 2005 and January 2013, 41 neonates underwent bilateral pulmonary artery banding followed by ductal stenting by means of a sternotomy at a median age of 6 days (range, 2 to 18 days) and weight of 2.6 kg (range, 1.5 to 3.7 kg). Thirty-five patients had hypoplastic left heart syndrome, and 6 patients had critical aortic stenosis with hypoplastic left ventricle. Primary indications for the hybrid procedure were low birth weight in 17 patients, hypoplastic left ventricle with the possibility of later biventricular repair in 6 patients, intact or near-intact atrial septum in 5 patients, and poor patient condition in 13 patients. Echocardiographic, angiographic, operative, and clinical data were reviewed. Outcomes were summarized with descriptive statistics and risk factors for mortality identified.
RESULTS: All but 6 patients had an antenatal diagnosis, and 24 patients were from other congenital cardiac centers. Nine patients had perioperative balloon aortic valvuloplasty, 1 patient had fetal balloon aortic valvuloplasty, and 17 patients had intervention to their atrial septum (41.4%). There were 9 inpatient deaths (21.9%) and 4 interstage deaths (9.8%) after the hybrid procedure. Twenty-eight patients subsequently underwent either the Norwood procedure (11 patients), combined stage I and II (14 patients), or biventricular repair (3 patients). No patient had heart transplantation. Among the patients who had combined stage I and II as a second procedure after the hybrid procedure, there were 2 early deaths, 1 late death before the Fontan, and 1 late death after the Fontan completion after combined stage I and II. All patients who had subsequent Norwood procedure were midterm survivors. Three of the 4 patients who had biventricular repair were midterm survivors. Overall survival was 56.1% at a median follow-up of 32.0 months. By univariate analysis, patient factors, intact or near-intact atrial septum, and aortic atresia were associated with nonsurvival.
CONCLUSIONS: Hybrid procedure as an alternative to the Norwood procedure offers good midterm survival in patients deemed at high risk for neonatal reconstruction.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26433522     DOI: 10.1016/j.athoracsur.2015.06.098

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  High risk HLHS: hybrid approach yes, but how does it work?

Authors:  Dietmar Schranz
Journal:  Transl Pediatr       Date:  2018-07

2.  Hybrid Strategy for High-Risk Neonates with Interrupted Aortic Arch: A Can Well Worth Kicking?

Authors:  Eva Kapravelou; David Anderson; Gareth J Morgan
Journal:  Int J Angiol       Date:  2017-04-19

Review 3.  Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.

Authors:  Richard G Ohye; Dietmar Schranz; Yves D'Udekem
Journal:  Circulation       Date:  2016-10-25       Impact factor: 29.690

Review 4.  Hypoplastic left heart syndrome (HLHS): molecular pathogenesis and emerging drug targets for cardiac repair and regeneration.

Authors:  Anthony T Bejjani; Neil Wary; Mingxia Gu
Journal:  Expert Opin Ther Targets       Date:  2021-09-15       Impact factor: 6.797

5.  First-stage palliation strategy for univentricular heart disease may impact risk for acute kidney injury.

Authors:  Bryan H Goldstein; Stuart L Goldstein; Prasad Devarajan; Farhan Zafar; David M Kwiatkowski; Bradley S Marino; David L S Morales; Catherine D Krawczeski; David S Cooper
Journal:  Cardiol Young       Date:  2017-09-11       Impact factor: 1.093

6.  Hybridizing the hybrid: a "serendipitous bridge" to heart transplantation in a child with hypoplastic left heart syndrome.

Authors:  Sanjog Rawtani; Misty Reis; Sanjiv K Gandhi
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-01-09

Review 7.  Hypoplastic Left Heart: Stage-I Will be Performed Interventionally, Soon.

Authors:  Dietmar Schranz; Anoosh Esmaeili; Hakan Akintuerk
Journal:  Pediatr Cardiol       Date:  2021-04-19       Impact factor: 1.655

Review 8.  Hypoplastic left heart syndrome: from comfort care to long-term survival.

Authors:  Mouhammad Yabrodi; Christopher W Mastropietro
Journal:  Pediatr Res       Date:  2016-10-04       Impact factor: 3.756

9.  Apples to oranges: Making sense of hybrid palliation for hypoplastic left heart syndrome.

Authors:  Travis J Wilder; Christopher A Caldarone
Journal:  JTCVS Open       Date:  2020-10-15

Review 10.  What Interventional Cardiologists Are Still Leaving to the Surgeons?

Authors:  Worakan Promphan; Shakeel A Qureshi
Journal:  Front Pediatr       Date:  2016-06-13       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.